+467.0%
MRNA vs FHN
+11.5%
+455.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FHN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.5% | +5.9% | +5.0% |
| 7D | -1.1% | -1.2% | +0.1% | -2.0% |
| 30D | +126.1% | -4.8% | +130.9% | +122.9% |
| 3M | +190.0% | -0.7% | +190.8% | +181.2% |
| 6M | +157.2% | +10.6% | +146.6% | +140.0% |
| YTD | +388.2% | +4.6% | +383.6% | +361.6% |
| 1Y | +467.0% | +11.4% | +455.7% | +439.0% |
| All | +467.0% | +11.5% | +455.5% | +439.0% |
Cumulative growth
Daily Returns
Daily percentage return beside FHN.
Daily Out/Under-Performance
Portfolio return minus FHN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FHN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FHN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling